Membranous nephropathy in patients with rheumatoid arthritis: Relationship to gold therapy

Medicine (United States)

Volumn 57, Issue 4, 1978, Pages 319-327

  Samuels, B ^a   Lee, J C ^a   Engleman, E P ^a   Hopper, J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD;

GOLD THERAPY; KIDNEY DISEASE; RHEUMATOID ARTHRITIS;

ADULT; AMYLOIDOSIS; ARTHRITIS, RHEUMATOID; FEMALE; GOLD; HUMAN; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGE; NEPHROSIS, LIPOID; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0017852965     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/00005792-197807000-00003     Document Type: Article

References (55)

1. Adams, D. A., Goldman, R., Maxwell, M. H. and Latta, H.: Nephrotic syndrome associated with penicillamine therapy of Wilson's disease. Am. J. Med., 36: 330, 1974.
2. Allander, E., Bucht, H., Lovgren, O. and Wehle, B.: Renal function in rheumatoid arthritis. Acta Rheum. Scand., 9: 116, 1963.
3. Baggenstoss, A. H. and Rosenberg, E. F.: Vis ceral lesions associated with chronic infections (rheumatoid) arthritis. Arch. Pathol., 35: 503, 1943.
4. Beregi, E. and Varga, I.: Analysis of 260 cases of membranous glomerulonephritis in renal biopsy material. Clin. Nephrol., 2: 216, 1974.
5. Boyle, J. A. and Buchanan, W. W.: Clinical Rheumatology. F. A. Davis Co., Philadelphia, 1971, p. 160.
6. Brun, C. and Raaschou, F.: The localization of gold in human kidney following chrysotherapy. A biopsy study. Nephron, 1: 265, 1964.
7. Brun, C., Olsen, S. T., Raaschou, F. and Sorensen, A. W. S.: Renal biopsy in rheumatoid arthritis. Nephron, 2: 65, 1965.
8. Burry, H. C.: Renal disorders in rheumatoid arthritis. Rheum. Phys. Med., 11: 2, 1971.
9. Burry, H. C.: Reduced glomerular function in rheumatoid arthritis. Ann. Rheum. Dis., 31: 65, 1972.
10. Camp, A. V., Mowat, A. G., Fletcher, W. B., Dunnhill, M. S. and Mclver, A. G.: A study of renal disease in rheumatoid arthritis. Ann. Rheum. Dis., 32: 278, 1973.
11. Cathcart, E. S. and O'Sullivan, J. B.: Rheuma toid arthritis in a New England town. A prevalence study in Sudbury, Mass. N. Engl. J. Med., 282: 421, 1970.
12. Clausen, E. and Pedersen, J.: Necrosis of the renal papillae in rheumatoid arthritis. Acta Med. Scand., 170: 631, 1961.
13. Cobb, S., Anderson, F. and Bauer, W.: Length of life and cause of death in rheumatoid arthritis. N. Engl. J. Med., 249: 553, 1953.
14. Crawhall, J. C. and Watts, R. W. E.: Some complications of cystinuria with D. penicillamine and nacetyl-d-penicillamine. Postgrad. Med. J., 44 (Suppl); 8, 1968.
15. Cruickshank, B.: Rheumatoid arthritis and rheumatoid disease. Proc. R. Soc. Med., 50: 462, 1967.
16. Duthie, J. J. R., Brown, P. E., Truelove, L. H., Baragar, F. D. and Lawrie, A. J.: Course and prognosis in rheumatoid arthritis. A further report. Ann. Rheum. Dis., 23: 193, 1964.
17. Ehrenriech, T. and Churg, J.: Pathology of membranous nephropathy. Pathol. Annu., 3: 145, 1968.
18. Forland, M. and Spargo, B. H.: Clinicopathologic correlations in idiopathic nephrotic syndrome with membranous nephropathy. Nephron, 6: 498, 1969.
19. Gerber, R. C., Paulus, H. E., Bluestone, R., et al: Kinetics of aurothiomalate in serum and synovial fluid. Arthritis Rheum., 15: 625, 1972.
20. Gluck, M. C., Gallo, G., Lowenstein, J. and Baldwin, D. S.: Membranous glomerulonephritis: Evolution of clinical and pathologic features. Ann. Intern. Med., 78: 1, 1973.
21. Golde, D. and Epstein, W.: Mixed cryoglobulins and glomerulonephritis. Ann. Intern. Med., 69: 1221, 1968.
22. Gottlieb, N. L., Smith, P. M. and Smith, E. M.: Gold excretion correlated with clinical course during chrysotherapy in rheumatoid arthritis. Arthritis Rheum., 15: 582, 1972.
23. Grausz, H., Earley, L. E., Stephens, B. G., Lee, J. C. and Hopper, J., Jr.: Diagnostic import of virus-like particles in the glomerular endothelium of patients with systemic lupus erythematosus. N. Engl. J. Med., 283: 506, 1970.
24. Hadley, W. K. and Rosenau, W.: Study of hu man renal disease by immunofluorescent methods. Arch. Pathol., 83: 342, 1967.
25. Hayslett, J. P., Kashgarian, M., Bensch, K. G., Spargo, B. H., Freedman, L. R. and Epstein, F. H.: Clinicopathological correlations in the nephrotic syndrome due to primary renal disease. Medicine, 52: 93, 1973.
26. Hopper, J., Jr., Lee, J. C. and Lewis, M. L.: Membranous nephropathy treatment with glucocorticoids. Abstracts of the Fifth International Congress of Nephrology, Mexico City, 1972, p. 101.
27. Hopper, J., Jr., Ryan; P., Lee, J. C. and Rosenau, W.: Lipoid nephrosis in 31 adult patients: Renal biopsy study by light, electron, and fluorescence microscopy with experience in treatment. Medicine, 49: 321, 1970.
28. Lee, J. C., Dushkin, M., Eyring, E. J., Engleman, E. P. and Hopper, J., Jr.: Renal lesions associated with gold therapy: Light and electron microscopic studies. Arthritis Rheum., 8: 1, 1965.
29. Lee, J. C., Yamauchi, H. and Hopper, J., Jr.: The association of cancer and the nephrotic syndrome. Ann. Intern. Med., 64: 41, 1966.
30. Mascarenhas, B. R., Granda, J. L. and Freyberg, R. H.: Gold metabolism in patients with rheumatoid arthritis treated with gold compounds reinvestigated. Arthritis Rheum., 15: 391, 1972.
31. Meltzer, M., Franklin, E. C., Elias, K., McCluskey, R. T. and Cooper, N.: Cryoglobulinemia-A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am. J. Med., 40: 837, 1966.
32. Morel-Maroger, L., Leathern, A. and Richet, G.: Glomerular abnormalities in nonsystemic diseases. Am. J. Med., 53: 170, 1972.
33. Nagi, A. H., Alexander, F. and Barabas, A. Z.: Gold nephropathy in rats -light and electron microscopic studies. Exp. Mol. Pathol., 15: 354, 1971.
34. Nagy, E. L., Mahallawy, M. and Sabour, M. S.: Renal lesions in rheumatoid arthritis. Lancet, 2: 852, 1959.
35. Neild, G. H., Gartner, H. V. and Bohle, A.: D. penicillamine-induced membranous glomerulonephritis. Lancet, 1: 1201, 1975.
36. Ozdemir, A. I., Wright, J. R. and Callyns, E.: Influence of rheumatoid arthritis on amyloidosis of aging. Comparison of 47 rheumatoid patients with 47 controls matched for age and sex. N. Engl. J. Med., 285: 534, 1971.
37. Pasternack, A., Wegelius, O. and Makisara, P.: Renal biopsy in rheumatoid arthritis. Acta Med. Scand., 182: 591, 1967.
38. Pollak, V. E., Pirani, C. L., Steck, I. E. and Kark, R. M.: The kidney in rheumatoid arthritis. Studies by renal biopsy. Arthritis Rheum., 5: 1, 1962.
39. Pollak, V. E., Rosen, S., Pirani, C. L., Muercke, R. C. and Kark, R. M.: Natural history of lipoid nephrosis and membranous glomerulonephritis. Ann. Intern. Med., 69: 1171, 1968.
40. Renal disease and rheumatoid arthritis. Lancet, 2: 1451, 1966.
41. Ropes, M. W. and a Committee of the American Rheumatism Association: 1958 revision of the diagnostic criteria for rheumatoid arthritis. Ann. Rheum. Dis., 18: 49, 1959.
42. Rosen, S.: Membranous glomerulonephritis. Current status. Hum. Pathol., 2: 209, 1971.
43. Rosenberg, L. E. and Hayslett, J. P.: Nephro toxic effects of penicillamine in cystinuria. J.A.M.A., 201: 698, 1967.
44. Row, P. G., Cameron, J. S., Turner, D. R., Evans, D. J., White, R. H. R., Ogg, C. S., Chantler, C. and Brown, C. B.: Membranous nephropathy. Q. J. Med., 44: 207, 1975.
45. Short, C. L., Bauer, W. and Reynolds, W. E.: Rheumatoid Arthritis: A Definition of the Disease and a Clinical Description Based on a Numerical Study of 293 Patients and Controls. Harvard University Press, Cambridge, Mass., 1957, p. 357.
46. Silverberg, D. S., Kidd, E. G., Shnitka, T. K. and Ulan, R. A.: Gold nephropathy. A clinical and pathologic study. Arthritis Rheum., 13: 812, 1970.
47. Sorensen, A. W. S.: Investigation of the kidney function in rheumatoid arthritis. Acta Rheum. Scand., 6: 115, 1960.
48. Sorensen, A. W. S.: The kidney function in pa tients with rheumatoid arthritis in relation to the commencement of the disease (VI). Acta Rheum. Scand., 10: 11, 1964.
49. Sorensen, A. W. S.: The Kidney in Rheumatoid Arthritis. Copenhagen, Munksgaard, 1966
50. Sorensen, A. W. S.: The Waaler-Rose test in patients suffering from rheumatoid arthritis in relationship to 24-hour endogenous creatinine clearance (III). Acta Rheum. Scand., 7: 304, 1961.
51. Strunk, S. W. and Ziff, M.: Ultrastructural studies of the passage of gold thiomalate across the renal glomerular capillary wall. Arthritis Rheum., 13: 39, 1970.
52. Teilum, G. and Lindahl, A.: Frequency and sig-nificance of amyloid changes in rheumatoid arthritis. Acta Med. Scand., 149: 449, 1954.
53. Tornroth, T. and Skvifvars, B. O.: Gold nephrop athy prototype of membranous glomerulonephritis. Am. J. Pathol., 75: 573, 1974.
54. Vaamonde, C. A. and Hunt, F. R.: The ne phrotic syndrome as a complication of gold therapy. Arthritis Rheum., 13: 826, 1970.
55. Ziff, M. and Barum, J.: Laboratory findings in rheumatoid arthritis, in Arthritis and Allied Conditions, a Textbook of Rheumatology. 8th Edition, ed. by J. L. Hollander and D. J. McCarty, Jr. Lea and Febiger, Philadelphia, 1972, p. 377.